Leading the Way in Life Science Technologies

GEN Exclusives

More »

Tech Notes

More »
Aug 1, 2009 (Vol. 29, No. 14)

High-Throughput Nanovolume qPCR

Next-Generation Platform Combines Microarray Throughput with Sensitivity

  • Smartchip Research Programs

    The SmartChip system is currently being used in gene-expression research at the University of Pittsburgh Medical Center and the University of Texas Southwestern Medical Center. These research programs are designed to identify and validate therapeutically relevant gene-expression biomarkers in chronic obstructive pulmonary disease, idiopathic pulmonary fibrosis, lung cancer, and wound healing. 

    Additionally, a SmartChip genotyping research collaboration has been established with scientists in the Institute for Genome Sciences and Policy at Duke University Medical Center. The focus of this program is the validation of SNPs that are related to breast cancer as well as an examination of the impact that validated SNPs have on patients’ disease prognosis and response to treatment. 



Related content

Be sure to take the GEN Poll

Scientifically Studying Ecstasy

MDMA (commonly known as the empathogen “ecstasy”) is classified as a Schedule 1 drug, which is reserved for compounds with no accepted medical use and a high abuse potential. Two researchers from Stanford, however, call for a rigorous scientific exploration of MDMA's effects to identify precisely how the drug works, the data from which could be used to develop therapeutic compounds.

Do you agree that ecstasy should be studied for its potential therapeutic benefits?

More »